Biotech VC Firm 28 Capital Emerges from Tiger Gene with New Platform
Life sciences venture capital firms continue to evolve their approaches to translating academic research into commercial therapies. Boston-based 28 Capital, co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, announced the launch of a new platform focused on […]
Biotech VC Firm 28 Capital Emerges from Tiger Gene with New Platform Read More »